Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma

Journal of Human Genetics

Volumn 58, Issue 8, 2013, Pages 508-516

  Yoshino, Hirofumi ^a   Enokida, Hideki ^a   Itesako, Toshihiko ^a   Tatarano, Shuichi ^a   Kinoshita, Takashi ^b   Fuse, Miki ^b   Kojima, Satoko ^c   Nakagawa, Masayuki ^a   Seki, Naohiko ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 200;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

BASE SEQUENCE; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHROMOSOMES, HUMAN; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; KIDNEY NEOPLASMS; MICRORNAS; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84883262705     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2013.31     Document Type: Article

References (43)

1. Gupta, K., Miller, J. D., Li, J. Z., Russell, M. W. & Charbonneau, C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat. Rev 34, 193-205 (2008)
2. Hadoux, J., Vignot, S. & De La Motte Rouge, T. Renal cell carcinoma: focus on safety and efficacy of temsirolimus. Clin. Med. Insights Oncol. 4, 143-154 (2010)
3. Margulis, V., Master, V. A., Cost, N. G., Leibovich, B. C., Joniau, S., Kuczyk, M. et al. International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma. Eur. Urol. 60, 673-683 (2011)
4. Carthew, R. W. & Sontheimer, E. J. Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642-655 (2009)
5. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004)
6. Calin, G. A. & Croce, C. M. MicroRNA signature in human cancers. Nat. Rev. Cancer 6, 857-866 (2006)
7. Wu, X., Weng, L., Li, X., Guo, C., Pal, S. K., Jin, J. M. et al. Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One 7, e35661 (2012)
8. Hidaka, H., Seki, N., Yoshino, H., Yamasaki, T., Yamada, Y., Nohata, N. et al. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma. Oncotarget 3, 44-57 (2012)
9. Wulfken, L. M., Moritz, R., Ohlmann, C., Holdenrieder, S., Jung, V., Becker, F. et al. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS One 6, e25787 (2011)
10. White, N. M., Bao, T. T., Grigull, J., Youssef, Y. M., Girgis, A., Diamandis, M. et al. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J. Urol. 186, 1077-1083 (2011)
11. Weng, L., Wu, X., Gao, H., Mu, B., Li, X., Wang, J. H. et al. MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J. Pathol. 222, 41-51 (2010)
12. Liu, H., Brannon, A. R., Reddy, A. R., Alexe, G., Seiler, M. W., Arreola, A. et al. Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell renal cell carcinoma. BMC Syst. Biol. 4, 51 (2010)
13. Juan, D., Alexe, G., Antes, T., Liu, H., Madabhushi, A., Delisi, C. et al. Identification of a microRNA panel for clear-cell kidney cancer. Urology 75, 835-841 (2010)
14. Chow, T. F., Youssef, Y. M., Lianidou, E., Romaschin, A. D., Honey, R. J., Stewart, R. et al. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin. Biochem. 43, 150-158 (2010).
15. Jung, M., Mollenkopf, H. J., Grimm, C., Wagner, I., Albrecht, M., Waller, T. et al. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J. Cell. Mol. Med. 13, 3918-3928 (2009)
16. Nakada, C., Matsuura, K., Tsukamoto, Y., Tanigawa, M., Yoshimoto, T., Narimatsu, T. et al. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J. Pathol 216, 418-427 (2008)
17. Huber, M. A., Kraut, N. & Beug, H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell. Biol. 17, 548-558 (2005).
18. Xu, J., Lamouille, S. & Derynck, R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19, 156-172 (2009)
19. Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell. Biol. 10, 593-601 (2008)
20. Sobin, L. H., Gospodarowicz, M. K. & Wittenkind, C. TNM Classification of Malignant Tumours, 7th ed. International Union Against Cancer 255-257 (Wiley-Liss, New York, NY, USA, 2009)
21. Nohata, N., Hanazawa, T., Kikkawa, N., Mutallip, M., Fujimaru, L., Yoshino, H. et al. Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. Int. J. Oncol. 38, 209-217 (2011)
22. Kawakami, K., Enokida, H., Chiyomaru, T., Tatarano, S., Yoshino, H., Kagara, I. et al. The functional significance of MiR-1 and miR-133a in renal cell carcinoma. Eur. J. Cancer 48, 827-836 (2012)
23. Sugimoto, T., Seki, N., Shimizu, S., Kikkawa, N., Tsukada, J., Shimada, H. et al. The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma. Genes Chromosomes Cancer 48, 132-142 (2009)
24. Girgis, A. H., Iakovlev, V. V., Beheshti, B., Bayani, J., Squire, J. A., Bui, A. et al. Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma. Cancer Res. 72, 5273-5284 (2012)
25. Ladeiro, Y., Couchy, G., Balabaud, C., Bioulac-Sage, P., Pelletier, L. & Rebouissou, S. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47, 1955-1963 (2008)
26. Dahiya, N., Sherman-Baust, C. A., Wang, T. L., Davidson, B., Shih, I. e. M. & Zhang, Y. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One 18, e2436 (2008)
27. Kim, T., Veronese, A., Pichiorri, F., Lee, T. J., Jeon, Y. J., Volinia, S. et al. P53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J. Exp. Med. 208, 875-883 (2011)
28. Li, J., Karaplis, A. C., Huang, D. C., Siegel, P. M., Camirand, A. & Yang, X. F. PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target. J. Clin. Invest. 121, 4655-4669 (2011)
29. Nishigaki, Y., Ohsaki, Y., Toyoshima, E. & Kikuchi, K. Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients. Clin. Cancer Res. 5, 1473-1481 (1995)
30. Dougherty, K. M., Blomme, E. A., Koh, A. J., Henderson, J. E., Pienta, K. J., Rosol, T. J. et al. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma. Cancer Res. 59, 6015-6022 (1999)
31. Agouni, A., Sourbier, C., Danilin, S., Rothhut, S., Lindner, V., Jacqmin, D. et al. Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B. Carcinogenesis 28, 1893-1901 (2007)
32. Nishihara, M., Ito, M., Tomioka, T., Ohtsuru, A., Taguchi, T. & Kanematsu, T. Clinicopathological implications of parathyroid hormone-related protein in human colorectal tumours. J. Pathol. 187, 217-222 (1999)
33. Alipov, G. K., Ito, M., Nakashima, M., Ikeda, Y., Nakayama, T., Ohtsuru, A. et al. Expression of parathyroid hormone-related peptide (PTHrP) in gastric tumours. J. Pathol. 182, 174-179 (1997)
34. Deftos, L. J., Barken, I., Burton, D. W., Hoffman, R. M. & Geller, J. Direct evidence that PTHrP expression promotes prostate cancer progression in bone. Biochem. Biophys. Res. Commun. 327, 468-472 (2005)
35. Firkin, F., Seymour, J. F., Watson, A. M., Grill, V. & Martin, T. J. Parathyroid hormonerelated protein in hypercalcaemia associated with haematological malignancy. Br. J. Haematol. 94, 486-492 (1996)
36. Kissin, M. W., Henderson, M. A., Danks, J. A., Hayman, J. A., Bennett, R. C. & Martin, T. J. Parathyroid hormone related protein in breast cancers of widely varying prognosis. Eur. J. Surg. Oncol. 19, 134-142 (1993)
37. Kremer, R., Shustik, C., Tabak, T., Papavasiliou, V. & Goltzman, D. Parathyroidhormone- related peptide in hematologic malignancies. Am. J. Med. 100, 406-411 (1996)
38. Rankin, W., Grill, V. & Martin, T. J. Parathyroid hormone-related protein and hypercalcemia. Cancer 80, 1564-1571 (1997)
39. Truong, N. U., de B Edwardes, M. D., Papavasiliou, V., Goltzman, D. & Kremer, R. Parathyroid hormone-related peptide and survival of patients with cancer and hypercalcemia. Am. J. Med. 115, 115-121 (2003)
40. Howe, E. N., Cochrane, D. R. & Richer, J. K. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res. 13, R45 (2011).
41. Uhlmann, S., Zhang, J. D., Schwa?ger, A., Mannsperger, H., Riazalhosseini, Y., Burmester, S. et al. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene 29, 4297-4306 (2010)
42. Sun, T., Wang, C., Xing, J. & Wu, D. miR-429 modulates the expression of c-myc in human gastric carcinoma cells. Eur. J. Cancer 47, 2552-2559 (2011)
43. Williams, K. C., Renthal, N. E., Condon, J. C., Gerard, R. D. & Mendelson, C. R. MicroRNA-200a serves a key role in the decline of progesterone receptor function leading to term and preterm labor. Proc. Natl. Acad. Sci. USA 109, 7529-7534 (2012).